Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
August 5, 2006
Solid-phase synthesis and structure-activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists
Vu Ma, Anthony W Bannon, Jamie Baumgartner, et al.
Molecules (Basel, Switzerland)
|
April 3, 2021
Thermal Energy Storage and Heat Transfer of Nano-Enhanced Phase Change Material (NePCM) in a Shell and Tube Thermal Energy Storage (TES) Unit with a Partial Layer of Eccentric Copper Foam
Mohammad Ghalambaz, Seyed Abdollah Mansouri Mehryan, Kasra Ayoubi Ayoubloo, et al.
Aging Cell
|
August 6, 2017
Dyrk1 inhibition improves Alzheimer's disease-like pathology
Caterina Branca, Darren M Shaw, Ramona Belfiore, et al.
Journal of Natural Products
|
March 31, 2026
Barettin, a Nonopioid, Nonhallucinogenic Marine Natural Product with Antihyperalgesic Properties Mediated by 5HT2A Inverse Agonism
Caleb A Seekins, Michael Okine, Emily G Forrest, et al.
The Journal of Biological Chemistry
|
July 19, 2015
Zeta Inhibitory Peptide Disrupts Electrostatic Interactions That Maintain Atypical Protein Kinase C in Its Active Conformation on the Scaffold p62
Li-Chun Lisa Tsai, Lei Xie, Kim Dore, et al.
Molecules (Basel, Switzerland)
|
May 6, 2017
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes
Diego Muñoz-Torrero, Arduino A Mangoni, Catherine Guillou, et al.
Marine Drugs
|
June 25, 2026
Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition
Caleb A Seekins, Monique R Archuleta, Alexandria E Evans, et al.
Journal of Medicinal Chemistry
|
September 30, 2024
Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B
Gerrit Wilms, Kevin Schofield, Shayna Maddern, et al.
Molecules (Basel, Switzerland)
|
December 29, 2017
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-2
Diego Muñoz-Torrero, Arduino A Mangoni, Hong Liu, et al.
Science Signaling
|
August 14, 2014
Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastoma
Yael Kusne, Eugenio A Carrera-Silva, Anthony S Perry, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Bioorganic & Medicinal Chemistry Letters
|
August 5, 2006
Solid-phase synthesis and structure-activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists
Vu Ma, Anthony W Bannon, Jamie Baumgartner, et al.
Molecules (Basel, Switzerland)
|
April 3, 2021
Thermal Energy Storage and Heat Transfer of Nano-Enhanced Phase Change Material (NePCM) in a Shell and Tube Thermal Energy Storage (TES) Unit with a Partial Layer of Eccentric Copper Foam
Mohammad Ghalambaz, Seyed Abdollah Mansouri Mehryan, Kasra Ayoubi Ayoubloo, et al.
Aging Cell
|
August 6, 2017
Dyrk1 inhibition improves Alzheimer's disease-like pathology
Caterina Branca, Darren M Shaw, Ramona Belfiore, et al.
Journal of Natural Products
|
March 31, 2026
Barettin, a Nonopioid, Nonhallucinogenic Marine Natural Product with Antihyperalgesic Properties Mediated by 5HT2A Inverse Agonism
Caleb A Seekins, Michael Okine, Emily G Forrest, et al.
The Journal of Biological Chemistry
|
July 19, 2015
Zeta Inhibitory Peptide Disrupts Electrostatic Interactions That Maintain Atypical Protein Kinase C in Its Active Conformation on the Scaffold p62
Li-Chun Lisa Tsai, Lei Xie, Kim Dore, et al.
Molecules (Basel, Switzerland)
|
May 6, 2017
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes
Diego Muñoz-Torrero, Arduino A Mangoni, Catherine Guillou, et al.
Marine Drugs
|
June 25, 2026
Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition
Caleb A Seekins, Monique R Archuleta, Alexandria E Evans, et al.
Journal of Medicinal Chemistry
|
September 30, 2024
Discovery and Functional Characterization of a Potent, Selective, and Metabolically Stable PROTAC of the Protein Kinases DYRK1A and DYRK1B
Gerrit Wilms, Kevin Schofield, Shayna Maddern, et al.
Molecules (Basel, Switzerland)
|
December 29, 2017
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-2
Diego Muñoz-Torrero, Arduino A Mangoni, Hong Liu, et al.
Science Signaling
|
August 14, 2014
Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastoma
Yael Kusne, Eugenio A Carrera-Silva, Anthony S Perry, et al.
Page
of 9